Skip to content
CircuLite logo — Innovating heart failure treatment with minimally-invasive m...

CircuLite

Innovating heart failure treatment with minimally-invasive micro-pumps for enhanced long-term circulatory support, improving life quality for millions.

Founded 2004 Series D Total: $96.20M Health Care, Medical Devices

General Information

Company Name CircuLite
Founded Year 2004
Founders / Decision Makers
Team member
Industries Health Care, Medical Devices
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with CircuLite. To contact CircuLite, visit circulite.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CircuLite compare?

A PDF of CircuLite and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CircuLite soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CircuLite

CircuLite is a health care and medical devices startup founded in 2004. The company's slogan "Innovating heart failure treatment with minimally-invasive micro-pumps for enhanced long-term circulatory support, improving life quality for millions" reflects its core mission. CircuLite focuses on revolutionizing heart failure treatment by developing minimally-invasive micro-pumps for long-term partial circulatory support (PCS). The company's innovative approach aims to enhance a patient's native pumping capacity, offering a proactive and lower-risk treatment method. CircuLite's unique micro-pump platform allows the PCS devices to be small enough for superficial implantation using endovascular or minimally-invasive surgical techniques, akin to a pacemaker. The company received a significant $30.00M Series D investment on 30 November 2011, with contributions from Saints Capital, Forbion, and MacAndrews & Forbes, Incorporated as the investor consortium. CircuLite's innovative approach and strategic partnerships position it as a promising player in advancing heart failure treatment and improving the quality of life for millions of patients and their families within the healthcare industry.

Business keywords: Cardiovascular devices, Heart failure treatment, Micro-pumps, Partial circulatory support, Minimally-invasive surgery, Endovascular techniques, Chronic heart failure, Quality of life improvement, Medical innovation, Proactive treatment approach, Native pumping capacity enhancement, Long-term circulatory support, Medical device technology, Patient care enhancement

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $30.00M 3
Saints Capital, Forbion +1
30 Nov 2011
Series C $32.50M 4
Omnes Capital, Forbion +2
05 Jan 2010
Venture Round $11.50M -
07 Jul 2009
Series B $5.00M 5
Forbion, Oxford Bioscience Partners +3
23 Apr 2007
Series B $10.20M 2
Giza Venture Capital, Oxford Bioscience Partners
16 Jan 2007
Series A $7.00M 3
Giza Venture Capital, Oxford Bioscience Partners +1
03 Dec 2004

CircuLite Alternatives & Competitors

View All Alternatives
CircuLite vs

Presenting the ModulHeart. Low-risk heart support for patients with advanced heart failure

Series A
32 employees
Health Care, Medical Devices
CircuLite vs
Impulse Dynamics
Impulse Dynamics United States

A cardiac medical device company determined to improve the lives of heart failure patients through C...

Venture round
239 employees
Biotechnology, Health Care
CircuLite vs
BioVentrix
BioVentrix United States

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our missi...

Series A
17 employees
Biotechnology, Health Care

FAQ About CircuLite

Innovating heart failure treatment with minimally-invasive micro-pumps for enhanced long-term circulatory support, improving life quality for millions.
CircuLite was founded in 2004.
CircuLite operates in Health Care and Medical Devices. Its work centres on Cardiovascular devices, Heart failure treatment, Micro-pumps and Partial circulatory support.
CircuLite has completed 6 funding rounds, raising a total of $96.20M. The latest funding stage is Series D.
Top alternatives and competitors to CircuLite include Puzzle Medical Devices Inc., Impulse Dynamics, BioVentrix, Taurus Vascular, HighLife. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CircuLite and Puzzle Medical Devices Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CircuLite, https://bouncewatch.com/company/circulite, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout